You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Build somatic hypermutation (SHM) lineage trees from antibody repertoire sequencing data. Reconstruct clonal relationships between antibody sequences and visualize how B-cell receptor (BCR) clones diversify during somatic hypermutation and affinity maturation.
TenSixty Bio is an oncology-focused biotechnology company based in Cambridge, Massachusetts, working to revolutionize the treatment of cancer. The company combines biology, machine learning, and high-throughput technologies to build an atlas of antibody targets on the surface of cancer cells, discover novel cancer targets, and develop improved…
Infinimmune is a biotechnology company that discovers and engineers human-derived antibody therapeutics. Its Complete Human Sequencing and Anthrobody library-on-B-cell platform surface rare antibodies that evolution has already proven in people, and its GLIMPSE antibody language model characterizes and optimizes candidates in silico for clinical…
AbCellera (NASDAQ: ABCL) is a Vancouver-based antibody discovery and development company that integrates biology, computation, and engineering to develop antibody-based medicines. Its technology platform combines high-throughput single-cell antibody screening, GPCR and ion-channel capabilities, bispecifics, antibody-drug conjugates…
Align amplicon sequencing reads against your own reference construct instead of a germline database. Used for synthetic antibody and TCR libraries where diversity is engineered into defined regions of a known scaffold, and reports per-sample clonotypes with full alignment QC.
Adimab is a private biotechnology company founded in 2007, headquartered in Lebanon, New Hampshire, with a west coast office in Mountain View, California. It operates a proprietary yeast-based antibody discovery and engineering platform that combines fully human synthetic and immune libraries to generate specific, stable and developable IgGs…
Alloy Therapeutics is a biotechnology ecosystem company operating as a Product Development Organization that partners across discovery, preclinical, and clinical development. It combines proprietary AI/ML, real-world data, and tech-enabled scientific services across multiple therapeutic modalities, including monoclonal and bispecific antibodies…
Cradle is a Dutch–Swiss biotechnology software company founded in 2021 with headquarters in Amsterdam and an office in Zurich, building an AI-powered protein engineering platform for industrial biotech and biopharma R&D teams.